Introduction
============

Human biomonitoring (HBM) measures the levels of environmental chemicals or their metabolites in easily accessible body fluids and tissues ([@r2]), and reflects all routes of uptake---oral, dermal, inhalative---and all relevant sources. The power of HBM to identify spatial and temporal trends in human exposures has contributed successfully to initiate policy measures and to focus on protection of susceptible populations such as children and pregnant mothers. The ban of lead from gasoline was triggered by elevated blood lead levels in the National Health and Nutrition Examination Survey (NHANES) ([@r33]). Results of the German Environmental Survey (GerES) led to recommendations to avoid mercury-containing amalgam teeth fillings in children ([@r7]) and contributed to the restriction of phthalate use in plastics ([@r23]). Increasing levels of polybrominated diphenyl ethers (PBDEs) in maternal milk samples of Sweden have led to the gradual phasing out of lower brominated congeners of PBDEs ([@r31]).

Experience with human biomonitoring in the general population differs among European countries, with long-standing traditions in countries such as Germany ([@r6]), France ([@r22]), the Czech Republic ([@r15]), Belgium (Flanders) ([@r36]), and Spain (Pérez-Gómez 2013), whereas other countries have no experience at all.

The "European Environment and Health Action Plan" ([@r19]) prioritized the need to harmonize HBM in Europe to allow comparison of data among countries and provide tools for follow-up of temporal and spatial trends in chemical exposures. The preparation of the protocol, including the selection of chemicals and study populations, started in 2005 with the Expert team to Support BIOmonitoring in Europe (ESBIO) project. With the funding of the Consortium to Perform Human Biomonitoring on a European Scale (COPHES) and its demonstration project DEMOCOPHES, the feasibility of a harmonized HBM approach was tested ([@r26]). COPHES designed the final protocol and made justified choices for exposure biomarkers, sample size, and recruitment strategy. DEMOCOPHES allowed 17 European countries to put this protocol into practice. Selected chemicals included phthalates that are present in some consumer products and food packaging ([@r28]), mercury and cadmium as ubiquitous developmental toxicants of concern ([@r24]), and urinary cotinine ([@r3]) as a biomarker for exposure to cigarette smoke; urinary creatinine was included as a measure for urine dilution. Young children and mothers of childbearing age were selected as vulnerable populations. Mercury in hair ([@r12]) and urinary cadmium ([@r1]) are markers of chemicals that accumulate in the body over a longer time period; urinary phthalate metabolites ([@r43]) and cotinine ([@r3]) measured in spot urine samples represent short-term exposure.

Methods
=======

*Study design and participants*. The cross-sectional survey was designed to include 120 children (5--11 years of age) and their mothers in each country, with 60 mother--child pairs each in Cyprus and Luxembourg because of the countries' smaller populations. We sampled the children and mothers between September 2011 and February 2012, either through schools or population registries. These were convenience samples with equal shares in an urban and a rural location as defined according to regional standards. We included only healthy children and mothers (no metabolic disturbances), who had sufficient knowledge of the local language and had been living at least for 5 years at the sampling location. Details and rationale for the study design are reported by [@r9]. The sample size allowed us to estimate preliminary country-specific reference values ([@r34]) and a minimally important difference in mean biomarker values of 30% between countries (α = 0.05, β = 0.80). Fieldworkers from the national study centers were trained and instructions were provided centrally and adapted at national level to each country's language, cultural conventions, and ethical and legal requirements. Information on characteristics of the study population and potential determinants of internal exposure was obtained through personalized interviews using questionnaires. Standard operation procedures (SOPs) to collect hair and morning urine samples were implemented ([@r9]). The study was approved by ethics committees in each country (for a list of ethics committees per country, see Supplemental Material, Table S1); mothers and children gave written informed consent or assent, respectively. All procedures followed the national data protection requirements including notification to data protection authorities.

*Chemical analysis*. We established a Quality Assurance Program to guarantee the quality and comparability of analytical results among laboratories ([@r35]). Each participating laboratory received SOPs for sampling, sample conservation, and chemical analysis ([@r9]; [@r35]). We organized two interlaboratory comparison investigations and two external quality assessment schemes (ICI/EQUAS) with native control material (hair, urine) sent to all laboratories willing to participate. To evaluate the ICIs, we calculated consensus values as the mean of the results of the participating laboratories (after exclusion of outliers). To evaluate the EQUAS, we calculated assigned values (target values) from the results of experienced, renowned reference laboratories. Laboratories were defined as "qualified laboratories" if they participated successfully in at least one ICI and one EQUAS round or in two EQUAS rounds ([@r35]). The number of laboratories that qualified for each analyte was as follows: mercury, 15; cotinine, 9; cadmium, 14; phthalate metabolites \[monoethylhexyl phthalate (MEHP), 2-ethyl-5-hydroxyhexyl phthalate (5OH-MEPH), 2-ethyl-5-oxohexyl phthalate (5oxo-MEHP), monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), mono-*n*-butyl phthalate (MnBP), monoisobutyl phthalate (MiBP)\], 7; and creatinine, 14.

*Database management and statistical analysis*. National data centers applied uniform rules for database construction by using one centrally developed code book with predefined variable names, unities, formats, and coding rules. Quality controls on the data were performed with centrally developed programs (SAS or SPSS). These strict and uniform rules for database construction allowed us to pool all country-specific data into one central European database. We used SAS software, version 9.3 (SAS Institute Inc.) for analysis of the central database. We replaced values below the LOQ by LOQ/2 and transformed biomarker data to natural log-transformed concentrations (ln). We excluded samples with creatinine concentrations \< 300 mg/L or \> 3,000 mg/L from statistical analysis \[[@r41]\]. We calculated weighted geometric means (GM) \[95% confidence intervals (CIs)\] and 90th percentiles (P90) (95% CI) so that the countries were equally represented, except for Cyprus and Luxembourg, which contributed only half. Using multiple mixed regression models with country as random factor, we identified determinants of exposure biomarkers by including pre-specified confounders and significant covariates (*p* \< 0.25 from univariate model to enter and *p* \< 0.05 to stay) in a stepwise model. We expressed urinary biomarkers in micrograms per liter with urinary creatinine included as confounder. We expressed results as percent change (95% CI) of biomarker concentration for change of the determinant, after adjustment for all other variables in the model. (For detailed methodology and full models, see Supplemental Material, "Identification of determinants of exposure," "Comparison of results between countries," and Table S2.)

To compare biomarker values among countries, we compared the GM of a country with the European GM by mixed linear regression analysis, after adjustment for prespecified confounders ([Figure 1](#f1){ref-type="fig"}). To visualize similarity between the biomarker levels and between different countries and/or mothers and children from the same country, we generated a heat map using the clustergram function (Matlab, MathWorks Inc.) ([Figure 2](#f2){ref-type="fig"}). Hierarchical clustering with Euclidean distance metric and average linkage was used to generate the hierarchical tree. Before analysis, the GM of each country was divided by the European GM. The ratio was calculated for mothers and children separately and was logarithmically transformed (log~2~ base) to obtain symmetry around 0 \[= log~2~(1)\]. The nearest-neighbor method was applied to impute missing data.

![Overview of GMs (95% CIs) of biomarker concentrations (μg/L for urinary markers and μg/g for mercury in hair) in children and mothers of the participating countries. Country codes: BE, Belgium; CH, Switzerland; CY, Cyprus; CZ, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; HU, Hungary; IE, Ireland; LU, Luxembourg; PL, Poland; PT, Portugal; RO, Romania; SE, Sweden; SI, Slovenia; SK, Slovak Republic; UK, United Kingdom. NA, no biomarker data available. For phthalate abbeviations, see Table 2. All data for children are adjusted for age and sex; urinary metabolites are additionally adjusted for urinary creatinine; all data in mothers are adjusted for age; urinary metabolites are additionally adjusted for urinary creatinine; urinary cadmium is additionally adjusted for smoking. Light blue: GM of country significantly below European GM. Dark blue: GM of country is significantly above European GM. White: no significant difference between GM of country and European GM. For European GMs, see Table 2.](ehp.1408616.g001){#f1}

![Heat map showing clustering of biomarkers (dendrogram to the left side) and clustering of countries (dendrogram at the top). Red and blue intensities indicate fold increases and decreases, respectively (expressed as log~2~) in country-specific biomarker concentrations adjusted for age and sex relative to the European geometric mean. Abbreviations: Cd, cadmium; COT, cotinine; Hg, mercury. For country codes, see Figure 1. Country codes followed by M present concentrations in mothers; country codes followed by C present concentrations in children. Gray rectangles bordered in black lines indicate missing data.](ehp.1408616.g002){#f2}

To put the results in a health risk context, we calculated the proportion of individuals with levels above health-based guidance values ([@r4], [@r5]; [@r25]; [@r37]; [@r42]).

Results
=======

*Determinants of biomarker concentrations*. Descriptive statistics of 1,844 children and mothers included in the study are given in [Table 1](#t1){ref-type="table"}. Participants were equally recruited according to predefined strata of sex, age, and sampling area in each country. For descriptive statistics of the biomarkers and multiple regression models, see Supplemental Material, Tables S3--S19.

###### 

Descriptive statistics of the study population.

                              Children   Mothers                                                        
  --------------------------- ---------- -------------------- ------------ ------- -------------------- ------------
  Age (years)                 1,844      8 (7, 10)            5--12        1,844   39 (35, 42)          24--52
  Urinary creatinine (mg/L)   1,842      1,053 (784, 1,426)   10--3,120    1,839   1,163 (781, 1,618)   57--3,670
  Body height (cm)            1,819      135 (127, 145)       98--170      1,836   166 (161, 170)       145--191
  Body weight (kg)            1,820      30 (25, 36)          14--81       1,836   64 (58, 72)          35--186
  Body-mass index (kg/m²)     1,811      16.3 (14.9, 18.2)    10.0--36.1   1,833   23.2 (21.1, 26.3)    14.7--62.2

                                            Children       Mothers                                                          
  ----------------------------------------- -------------- ---------------------- -------------- ------- ------------------ -------------
  Sex                                       1,844          Boy                    912 (49.5)     1,844   Woman              1,844 (100)
  Girl                                      932 (50.5)                                                                      
  Area of residence                         1,844          Rural                  923 (50.1)     1,844   *As in children*   
  Urban                                     921 (49.9)                                                                      
  Highest educational level of the family   1,843          Primary (ISCED 0--2)   166 (9.0)      1,843   *As in children*   
  Secondary (ISCED 3--4)                    607 (32.9)                                                                      
  Tertiary (ISCED 5--6)                     1,070 (58.1)                                                                    
  Smoking habits                            1,844          Smoker                 0 (0)          1,844   Daily smoker       283 (15.3)
  Nonsmoker                                 1,844 (100)    Occasional smoker      106 (5.7)                                 
  Former smoker                             401 (21.7)                                                                      
  Never smoker                              1,054 (57.2)                                                                    
  ETS at home (nonsmokers only)             1,842          Daily                  179 (9.7)      1,450   Yes                162 (11.2)
  Less than daily                           130 (7.1)      No                     1,288 (88.8)                              
  Never                                     1,533 (83.2)                                                                    
  ETS elsewhere (nonsmokers only)           1,842          Yes                    775 (42.1)     1,455   Yes                827 (56.8)
  No                                        1,067 (57.9)   No                     628 (43.2)                                
  ETS in last 24 hr (nonsmokers only)       1,840          Yes                    232 (12.6)     1,450   Yes                164 (11.3)
  No                                        1,608 (87.4)   No                     1,286 (88.7)                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                           Children       Mothers                                                                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- ------------------------ --------------------- -------------- --------------------- ------------
  Fish consumption (all types)                                                                                                                                                                                                                                                                                                                                                                                                                             1,844          Several times/week       442 (24.0)            1,844          Several times/week    483 (26.2)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,402 (76.0)   Once a week or less      1,361 (73.8)                                               
  Consumption of sea fish                                                                                                                                                                                                                                                                                                                                                                                                                                  1,840          Several times/week       283 (15.4)            1,840          Several times/week    294 (16.0)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,557 (84.6)   Once a week or less      1,546 (84.0)                                               
  Consumption of shellfish                                                                                                                                                                                                                                                                                                                                                                                                                                 1,820          Several times/week       194 (10.7)            1,826          Several times/week    355 (19.4)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,626 (89.3)                            Once a week or less   1,471 (80.6)                         
  Consumption of freshwater fish                                                                                                                                                                                                                                                                                                                                                                                                                           1,815          Several times/week       248 (13.7)            1,818          Several times/week    298 (16.4)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,567 (86.3)   Once a week or less      1,520 (83.6)                                               
  Consumption of seafood products                                                                                                                                                                                                                                                                                                                                                                                                                          1,811          Several times/month      94 (5.2)              1,811          Several times/month   154 (8.5)
  Once a month or less                                                                                                                                                                                                                                                                                                                                                                                                                                     1,717 (94.8)   Once a month or less     1,657 (91.5)                                               
  Consumption of ice cream                                                                                                                                                                                                                                                                                                                                                                                                                                 1,821          Several times/week       185 (10.2)            1,829          Several times/month   536 (29.3)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,636 (89.8)   Once a month or less     1,293 (70.7)                                               
  Consumption of chewing gum                                                                                                                                                                                                                                                                                                                                                                                                                               1,662          Several times/week       578 (34.8)            1,675          Several times/week    626 (37.4)
  Once a week or less                                                                                                                                                                                                                                                                                                                                                                                                                                      1,084 (65.2)   Once a week or less      1,049 (62.6)                                               
  Use of personal care products^*a*^                                                                                                                                                                                                                                                                                                                                                                                                                       1,816          High or moderate         822 (45.3)            1,806          High                  861 (47.7)
  Low                                                                                                                                                                                                                                                                                                                                                                                                                                                      994 (54.7)     Moderate or low          945 (52.3)                                                 
  PVC in house                                                                                                                                                                                                                                                                                                                                                                                                                                             1,773          PVC in floors or walls   342 (19.3)            1,773          *As in children*      
  No PVC                                                                                                                                                                                                                                                                                                                                                                                                                                                   1,431 (80.7)                                                                                       
  Abbreviations: ETS, environmental tobacco smoke; ISCED, International Standard Classification of Education; P25, 25th percentile; P75, 75th percentile; PVC, polyvinyl chloride. ^***a***^Use of personal care products (PCPs) is calculated as a score based on the frequency (never to daily) of nine PCP groups (makeup, eye makeup, shampoo, hair-styling products, body lotions and creams, fragrances, deodorant, massage oil, and nail polish).                                                                                                      

Fish consumption was the major predictor of mercury levels in hair, both in children and in mothers (see Supplemental Material, Tables S4 and S5). Consumption of sea fish, shellfish, or freshwater fish in the preceding 4 weeks independently contributed to mercury levels in the body. In multiple regression models, frequent (several times/week) compared to sporadic (once/week or less) sea fish consumption was associated with 46% (95% CI: 26, 69%) higher mercury levels in children and 51% (95% CI: 34, 71%) in mothers; shellfish with 56% (95% CI: 35, 79%) in children and 38% (95% CI: 24, 55%) in mothers, freshwater fish with 23% (95% CI: 8, 39%) in children and 23% (95% CI: 11, 37%) in mothers. The GM mercury levels of mothers were higher than those of the children ([Table 2](#t2){ref-type="table"}), but levels of mothers and children were highly correlated (Spearman's *r* = 0.72, *p* \< 0.001, *n* = 1,833). Older mothers had 15% (95% CI: 5, 24%) higher levels compared to the youngest age group (see Supplemental Material, Table S5). Younger children of 5--8 years showed 8% (95% CI: 0, 17%) higher levels compared with the older group of 9--11 years (see Supplemental Material, Table S4). Participants from families with a higher educational level (tertiary vs. primary education) had 19% (95% CI: 4, 31%) higher levels of mercury in children and 25% (95% CI: 13, 36%) in mothers.

###### 

European exposure values in children and mothers in the COPHES/DEMOCOPHES study and for those in NHANES.

  Biomarker of exposure                  COPHES/DEMOCOPHES study   NHANES^*d*^                                                                                                                                                                                                                                      
  -------------------------------------- ------------------------- ------------- ---------------------- ---------------------- -------------------------------------------------------------- ------------ ------- ------------------------------------------------------------------------------------------------ ----------------------
  Children                                                                                                                                                                                                                                                                                                          
  Mercury in hair (μg/g)                 1,836                     85.9          0.145 (0.139, 0.151)   0.800 (0.698, 0.917)   JECFA: *n*= 25 (1.4)                                           1999--2000   838     0.12 (0.10, 0.12)                                                                                0.41
  Urinary cotinine (μg/L)                1,818                     57.6          0.80 (0.76, 0.84)      4.90 (3.90, 6.16)      ---                                                            ---          ---     ---                                                                                              ---
  Urinary cadmium (μg/L)                 1,698                     70.1          0.071 (0.069, 0.074)   0.220 (0.209, 0.232)   HBM-I: *n*= 6 (0.4) HBM--II: *n*= 0 (0.0) BE: *n*= 0 (0.0)     2009--2010   415     0.057 (0.053, 0.061)                                                                             0.130 (0.120, 0.160)
  Urinary DEHP metabolites (μg/L)^*e*^   1,816                     85.6          47.6 (46.0, 49.3)      137 (126, 150)         HBM-I: *n*= 12 (0.6) BE: *n*= 53 (2.9)                         2009--2010   415     MEHP: 1.64 (1.45, 1.85) 5OH-MEHP: 15.0 (13.2, 17.1) 5-oxo-MEHP: 9.87 (8.72, 11.0) ∑(GM) = 26.5   
  Urinary MEP (μg/L)                     1,816                     98.0          34.4 (32.8, 36.0)      159 (138, 183)         BE: *n*= 0 (0.0)                                               2009--2010   415     35.2 (31.2, 39.8)                                                                                151 (114, 207)
  Urinary MBzP (μg/L)                    1,816                     95.2          7.1 (6.8, 7.5)         27.8 (25.2, 30.6)      BE: *n*= 0 (0.0)                                               2009--2010   415     11.6 (9.51, 14.1)                                                                                63.9 (47.4, 76.8)
  Urinary MnBP (μg/L)                    1,355                     99.9          34.8 (33.5, 36.2)      95.5 (87.3, 104.5)     ---                                                            2009--2010   415     21.7 (19.0, 24.8)                                                                                83.8 (59.6, 121)
  Urinary MiBP (μg/L)                    1,355                     99.8          45.4 (43.6, 47.3)      131 (117, 147)         ---                                                            2009--2010   415     10.2 (9.10, 11.4)                                                                                35.7 (28.8, 46.9)
  Mothers                                                                                                                                                                                                                                                                                                           
  Mercury in hair (μg/g)                 1,839                     90.5          0.225 (0.216, 0.234)   1.200 (1.068, 1.349)   JECFA: *n*= 62 (3.4)                                           1999--2000   1,726   0.20 (0.16, 0.24)                                                                                1.11
  Urinary cotinine (μg/L)                1,800                     62.4          2.75 (2.41, 3.14)      1,182 (974, 1,434)     ---                                                            ---          ---     ---                                                                                              ---
  Urinary cadmium (μg/L)                 1,685                     93.8          0.219 (0.211, 0.228)   0.620 (0.580, 0.663)   HBM-I: *n*= 49 (2.9) HBM--II: *n*= 0 (0.0) BE: *n*= 26 (1.5)   2009--2010   1,450   0.188 (0.172, 0.206)                                                                             0.740 (0.620, 0.880)
  Urinary DEHP metabolites (μg/L)^*e*^   1,800                     81.6          29.2 (28.1, 30.3)      91 (84, 100)           HBM-I: *n*= 19 (1.0) BE: *n*= 28 (1.5)                         2009--2010   1,350   MEHP: 1.39 (1.21, 1.60) 5OH-MEHP: 11.0 (9.58, 12.8) 5-oxo-MEHP: 7.09 (6.17, 8.14) ∑(GM) = 19.5   
  Urinary MEP (μg/L)                     1,800                     95.2          48.2 (45.6, 51.0)      252 (221, 287)         BE: *n*= 0 (0.0)                                               2009--2010   1,350   67.8 (60.3, 76.4)                                                                                548 (392, 675)
  Urinary MBzP (μg/L)                    1,800                     91.8          4.5 (4.3, 4.7)         17.7 (16.1, 19.5)      BE: *n*= 0 (0.0)                                               2009--2010   1,350   6.04 (5.38, 6.77)                                                                                29.3 (24.5, 36.9)
  Urinary MnBP (μg/L)                    1,347                     99.4          23.9 (23.0, 24.9)      66.2 (60.5, 72.4)      ---                                                            2009--2010   1,350   14.7 (13.1, 16.5)                                                                                57.7 (52.7, 63.9)
  Urinary MiBP (μg/L)                    1,347                     99.4          30.1 (28.9, 31.4)      88 (81, 96)            ---                                                            2009--2010   1,350   7.50 (6.68, 8.43)                                                                                29.1 (25.3, 33.5)

Cadmium levels in mothers were significantly higher in active smoking mothers and this was independent of age. The GMs were higher in mothers than in children ([Table 2](#t2){ref-type="table"}). Older mothers had 25% (95% CI: 18, 32%) higher levels than younger mothers (see Supplemental Material, Table S9). Levels in mothers and children showed a low but significant correlation (Spearman's *r* = 0.24, *p* \< 0.001, *n* = 1,660). After adjustment for age and smoking, mothers from families with a tertiary education had 34% (95% CI: 17, 54%) lower levels compared with those with a primary education. In children, except for age and creatinine, no significant determinants were identified (see Supplemental Material, Table S8).

The urinary levels of MEHP, 5OH-MEHP and 5oxo-MEH were highly correlated (Pearson's *r* \> 0.70), so their sum was used in the analyses. The GMs of urinary phthalate metabolites \[except MEP, related to use of personal care products (PCPs)\] were higher in children than in mothers ([Table 2](#t2){ref-type="table"}). Phthalate levels of mothers and children were significantly correlated (*p* \< 0.001): Spearman's *r* ranged between 0.40 and 0.49. Multiple regression models ([Table 3](#t3){ref-type="table"}) showed that younger children of 5--8 years showed higher levels compared with the older group of 9--11 years. Participants from families who reported having PVC (polyvinyl chloride) floors or walls had significantly increased levels of MBzP and MiBP in children and mothers and of MnBP in children ([Tables 3](#t3){ref-type="table"} and [4](#t4){ref-type="table"}). A small effect for MiBP was seen in mothers who reported renovation in the house in the previous 2 years. Frequent use of PCPs increased urinary MEP levels in mothers and children and urinary MiBP levels in children. Unexpectedly, urinary levels of di(2-ethylhexyl) phthalate (DEHP) metabolites and MnBP in mothers were lower in frequent PCP users. High consumption of ice cream was associated with higher urinary levels of DEHP metabolites and MBzP levels in children and with higher MnBP and MBzP levels in mothers. High consumption of chewing gum was related to higher urinary levels of DEHP metabolites in children and to higher MEP levels in mothers. After adjustment for confounders and significant covariates, educational level was still a predictor of phthalate biomarkers---that is, significantly higher urinary levels were found for DEHP metabolites in mothers from families with a primary education, for MiBP (mothers) and MEP (children) in families with secondary education, and for MnBP (children) in families with tertiary education.

###### 

Determinants of exposure to urinary phthalate metabolites (μg/L): multiple regression models in children.

  Parameters                           Category               Estimate (95% CI) for change (multiplicative factor)                                                               
  ------------------------------------ ---------------------- ------------------------------------------------------ ------------------- ------------------- ------------------- -------------------
  Age^*a*^                             5--8 years             1.19 (1.11, 1.27)                                      1.15 (1.04, 1.26)   1.15 (1.06, 1.26)   1.15 (1.07, 1.24)   1.19 (1.10, 1.28)
  9--11 years                          1.00                   1.00                                                   1.00                1.00                1.00                
  Sex^*a*^                             Boys                   NS                                                     NS                  NS                  0.91 (0.85, 0.98)   0.92 (0.85, 0.99)
  Girls                                1.00                   1.00                                                                                                               
  Urinary creatinine level^*a*^        300--900 mg/L          0.46 (0.42, 0.51)                                      0.41 (0.36, 0.47)   0.41 (0.37, 0.47)   0.45 (0.41, 0.50)   0.45 (0.40, 0.50)
  900--1,500 mg/L                      0.75 (0.69, 0.83)      0.68 (0.61, 0.77)                                      0.69 (0.62, 0.78)   0.73 (0.66, 0.81)   0.72 (0.65, 0.80)   
  1,500--3,000 mg/L                    1.00                   1.00                                                   1.00                1.00                1.00                
  Urine sampling period                \< 10 hr               NS                                                     1.20 (1.06, 1.35)   NS                  NS                  NS
  10--11 hr                            1.14 (1.02, 1.29)                                                                                                                         
  ≥ 11 hr                              1.00                                                                                                                                      
  Morning urine                        Yes                    NS                                                     NS                  1.98 (1.17, 3.36)   NS                  NS
  No                                   1.00                                                                                                                                      
  Educational level of the family      Primary                NS                                                     0.91 (0.81, 1.03)   NS                  0.91 (0.81, 1.03)   NS
  Secondary                            0.89 (0.82, 0.97)      0.89 (0.82, 0.97)                                                                                                  
  Tertiary                             1.00                   1.00                                                                                                               
  Use of personal care products^*b*^   Moderate to high use   NS                                                     1.24 (1.13, 1.37)   NS                  NS                  1.13 (1.03, 1.23)
  Low use                              1.00                   1.00                                                                                                               
  Ice cream consumption                Several times/week     1.12 (1.01, 1.25)                                      NS                  1.18 (1.02, 1.36)   NS                  NS
  Once/week or less                    1.00                   1.00                                                                                                               
  Gum consumption                      Several times/week     1.10 (1.02, 1.18)                                      NS                  NS                  NS                  NS
  Once/week or less                    1.00                                                                                                                                      
  PVC in floors/walls                  Yes                    NS                                                     NS                  1.50 (1.34, 1.68)   1.19 (1.08, 1.32)   1.22 (1.09, 1.35)
  No                                   1.00                   1.00                                                   1.00                                                        

###### 

Determinants of exposure to urinary phthalate metabolites (μg/L): multiple regression models in mothers.

  Parameters                           Category              Estimate (95% CI) for change (multiplicative factor)                                                               
  ------------------------------------ --------------------- ------------------------------------------------------ ------------------- ------------------- ------------------- -------------------
  Age^*a*^                             ≤ 35 years            NS                                                     NS                  NS                  0.81 (0.73, 0.89)   NS
  35--40 years                         0.93 (0.86, 1.01)                                                                                                                        
  \> 40 years                          1.00                                                                                                                                     
  Body mass index                      Normal Weight         NS                                                     NS                  NS                  1.15 (1.02, 1.29)   NS
  Overweight                           1.09 (0.96, 1.24)                                                                                                                        
  Obese                                1.00                                                                                                                                     
  Urinary creatinine level^*a*^        300--900 mg/L         0.35 (0.32, 0.38)                                      0.32 (0.28, 0.37)   0.33 (0.30, 0.37)   0.35 (0.32, 0.38)   0.38 (0.35, 0.41)
  900--1,500 mg/L                      0.62 (0.57, 0.68)     0.63 (0.55, 0.72)                                      0.59 (0.54, 0.65)   0.60 (0.55, 0.66)   0.61 (0.56, 0.67)   
  1,500--3,000 mg/L                    1.00                  1.00                                                   1.00                1.00                1.00                
  Urine sampling period                \< 7 hr               0.87 (0.79, 0.97)                                      NS                  NS                  NS                  NS
  7--9 hr                              0.97 (0.88, 1.06)                                                                                                                        
  ≥ 9 hr                               1.00                                                                                                                                     
  Educational level of the family      Primary               1.20 (1.05, 1.37)                                      NS                  NS                  NS                  1.09 (0.97, 1.23)
  Secondary                            1.04 (0.96, 1.13)     1.11 (1.02, 1.21)                                                                                                  
  Tertiary                             1.00                  1.00                                                                                                               
  Use of personal care products^*b*^   High use              0.91 (0.84, 0.98)                                      1.40 (1.25, 1.56)   NS                  0.92 (0.86, 0.99)   NS
  Moderate to low use                  1.00                  1.00                                                   1.00                                                        
  Ice cream consumption                Several times/month   NS                                                     NS                  1.13 (1.03, 1.24)   1.10 (1.01, 1.19)   NS
  Once/month or less                   1.00                  1.00                                                                                                               
  Gum consumption                      Several times/week    NS                                                     1.19 (1.06, 1.34)   NS                  NS                  NS
  Once/week or less                    1.00                                                                                                                                     
  PVC in floors/walls                  Yes                   NS                                                     NS                  1.32 (1.19, 1.47)   NS                  1.15 (1.04, 1.26)
  No                                   1.00                  1.00                                                                                                               
  Renovation in house                  Yes                   NS                                                     NS                  NS                  NS                  1.08 (1.00, 1.16)
  No                                   1.00                                                                                                                                     

In mothers, the effect of active smoking on cotinine levels was dominant (see Supplemental Material, Table S7). Levels in mothers and children correlated strongly (Spearman's *r* = 0.71, *p* \< 0.001, *n* = 1,777). The younger children of 5--8 years showed 16% (8, 25%) higher levels compared to the older group of 9--11 years (see Supplemental Material, Table S6). In children, environmental tobacco smoke (ETS) at home was the strongest predictor. Compared with children who were never exposed to ETS at home, children with daily exposure had five times higher values \[504% (95% CI: 429, 593%)\], and children with less than daily exposure had almost double values \[181% (95% CI: 155, 211%)\]. Exposure to ETS in other places than home resulted in 19% (95% CI: 10, 29%) higher values. Compared with children from families with a tertiary education, those with a secondary education had 20% (95% CI: 10, 30%) higher cotinine levels in urine, and those with primary education had 49% (95% CI: 29, 72%) higher values.

*The geographical aspect*. Residence in urban or rural area was not a significant determinant of internal exposure at the European Union level. Only mercury in hair showed, independently of fish consumption, higher levels in urban areas compared with rural areas: 35% (95% CI: 23, 47%) higher in children and 30% (95% CI: 19, 41%) in mothers (see Supplemental Material, Tables S4 and S5).

The average biomarker concentrations varied significantly among the European countries. This holds for the unadjusted data (see Supplemental Material, Tables S20--S35) and for data after adjustment for age, sex, and weighting for equal group sizes ([Figure 1](#f1){ref-type="fig"}). The average biomarker concentrations of mercury in hair of Spanish and Portuguese children were, respectively, six and seven times higher than the European average. Cadmium varied less among the countries: Average urinary cadmium levels in Polish and Slovak mothers were respectively 1.9 and 1.7 times higher than the European average. In Romania and Hungary, average cotinine levels were, respectively, 2.4 and 2.2 times higher than the European average, reflecting the weak antismoking legislation in these countries. Swedish children had, on average, three times higher urinary MBzP levels than the average European value. Slovak children had almost twice the average European biomarker concentrations of DEHP metabolites, and Polish children showed the highest average levels of MnBP and MiBP. Average MEP levels in Spain were six times higher than the European average. The heat map ([Figure 2](#f2){ref-type="fig"}) shows that biomarker data from mothers and children clustered together except in the Czech Republic and the Slovak Republic. Overall the biomarker clustering followed geographical grouping. The Southern European countries (Spain, Portugal) clustered separately from the other countries; Eastern European countries (Romania, Hungary, Poland, the Czech Republic, and the Slovak Republic) formed a further cluster; Western European countries (Germany, Belgium, Luxembourg, and Denmark) also showed fairly good resemblance.

Although the sampling frame of the European biomonitoring program differs from that of the U.S. national program, the geometric means and P90 of COPHES/DEMOCOPHES are well in line with the results obtained in NHANES ([@r14]; [@r30]) ([Table 2](#t2){ref-type="table"}). For MiBP, higher values were observed in Europe compared with the United States (factor 3--4), in both mothers and children ([Table 2](#t2){ref-type="table"}). Differences for other biomarkers were modest, with a trend in Europe for lower biomarker concentrations of MBzP and MEP, higher concentrations of MnBP and DEHP, and similar levels for cadmium and mercury.

Available health-based guidance values allow us to put the observed biomarker concentrations in a risk context. Few participants exceeded these values ([Table 2](#t2){ref-type="table"}). The P90 of the biomarker values is far below the guidance values; only the urinary cadmium P90 of mothers and children was within a factor 2 of the concentration below which no risk for adverse health effects is expected ([@r37]), and for mercury they are below a factor 3.

Discussion
==========

This first Europe-wide program provides biomarker data from mothers and children of 17 European countries. Because we recruited in one rural and one urban area per country, our sample was not representative for the European Union population. Yet the recruited sample had a smoking behavior similar to that of the average European population ([@r17]). Also, the countries ranked in their reported fish consumption here according to national statistics ([@r21]). The educational level of the participants was skewed toward a higher educational level. The study design allowed us to conclude that exposure to mercury, cadmium, phthalates, and nicotine is widespread in the European population.

Differences in environment and lifestyle influenced individual biomarker values and country-specific averages. If we compared average levels among countries, the biomarker patterns varied according to geographic trends. Yet few study participants exceeded the available health-based guidance values. The major strength of our study is the comparable data from 17 European countries produced through a harmonized process, including the use of a commonly developed protocol, intensive training and capacity building for field work, chemical analyses, reporting and communication, as well as stringent quality control programs for chemical and data analysis. This allowed us to measure both well-known pollutants such as cadmium, cotinine, or mercury and emerging chemicals such as phthalates.

Our study identified younger children as more exposed than older children to phthalates (except MEP), cotinine, and mercury. These results are in line with U.S. data for exposure to phthalates ([@r38]) and ETS ([@r11]). The underlying reasons cannot be derived from this study but may be explained by higher exposure relative to body size through inhalation of dust or food intake; by typical exposure patterns in children, such as contact with toys, more time spent on the floor, and more frequent hand-to-mouth contact; or by differences in metabolism. Additionally, the higher cotinine levels in younger children might be attributable to the fact that they spend more time at home, and thus may be more exposed to nicotine, since smoking in public buildings is much more controlled than in private homes. We observed a significant influence of social class (represented by the highest educational level within the family) on each of the biomarker levels even after adjustment for confounders and significant covariates: Mercury level in hair increased in children and mothers if social class was higher, whereas cotinine, cadmium, and phthalate metabolites were lower with increasing educational level of the family. Perhaps underlying lifestyle factors that vary with socioeconomic status and that were not considered in the questionnaires may account for these findings. These associations between social class and biomarker concentrations are in line with U.S. data ([@r39]) and may be mediated partly by smoking, occupation, and diet (fish consumption, local food, convenience food). Our findings thus indicate that public health remediation measures to decrease environmental exposure and disease burden within a society should be stratified according to age groups and social strata within the population.

Fish consumption and social status were identified as important and independent determinants of mercury levels, both in mothers and children. This is in line with results from several populations with moderate to high fish consumption ([@r18]). Mercury levels in children and in women of childbearing age are important parameters to monitor because pre- and postnatal mercury exposure, even at low levels, has adverse neurodevelopmental effects ([@r27]). Although several high fish--consuming countries such as France, Finland, Lithuania, Malta, and Italy are not participating in DEMOCOPHES at present, 1.4% of the children and 3.4% of the mothers in our study population had mercury levels above the JECFA/WHO provisional threshold value of 2.3 μg/g hair ([@r42]). This proportion differs considerably by country, with 0% of participants exceeding the threshold in most Northern and Central European countries and up to 33% of the mothers with levels above the safe dose in countries with high fish consumption, with implications for loss of IQ points and costs ([@r10]). If these data urge policy makers to take actions, current biomarker concentrations can be used as baseline for follow-up, both for the exposure of the population and the environment. The major exposure route for DEHP is food ([@r28]). Therefore, we were not surprised to find an association between DEHP metabolites with chewing gum and ice cream consumption. Most probably, these two food items are not specific sources, but rather represent predilection for flavored, packaged, or processed food, and thus may be proxies for convenience food. The association between urinary MBzP and PVC materials in the home is in accordance with recent findings in children ([@r13]). Although high-molecular-weight phthalates such as DEHP are the major phthalates used in PVC, no association was found between the presence of PVC at home and urinary DEHP metabolites. Given that DEHP exposure is dominated by foods ([@r29]) and that DEHP house dust does not correlate with DEHP body burden ([@r8]), a significant correlation was not really expected. The lower levels of DEHP metabolites and MnBP in mothers who were high PCP users were not expected and may relate to cross-correlation with other personal habits. The relative levels of phthalate metabolites differ substantially among countries, which points to different sources, products on the market, or behavior characteristics. Despite legal restrictions on the use of DEHP, di-*n*-butyl phthalate, and diisobutyl phthalate as imposed by European Union directives, these compounds are still ubiquitous in Europeans. They are short-lived in the body, implying that exposures to these compounds are still part of current daily life. Diethyl phthalate, one of the principal phthalates in cosmetic products ([@r28]), is not yet restricted. High levels of its metabolite MEP were found.

The health impact of cigarette smoking is well documuented ([@r40]). The home environment appears to be the most important predictor of the cotinine levels in children. Further awareness of parents therefore is needed. The importance of anti-smoking legislation pays off, as countries with stronger legislation that has been longer in place showed the lowest cotinine levels ([@r20]). The effectiveness of anti-smoking legislation on health outcomes has been demonstrated on a population level ([@r16]).

Conclusion
==========

This HBM study presents the first steps, for Europe as a whole, to register internal chemical exposures at the individual level. Although the sampling protocol is not yet representative for the geographical distribution of the population in the country, the results show remarkable differences in the biomarker concentration profiles by country residence. Personal habits and lifestyle are strong determinants of internal exposure. The harmonized protocols and stringent quality control measures ensure that these are true differences, not related to variability in protocols, analytical measurements, or interpretation. These data offer policy makers direct means by which to evaluate whether implementation of protective measures and legislation related to chemicals are adequate to protect the health of the entire population or whether they need to be adjusted.

Supplemental Material
=====================
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Click here for additional data file.
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